Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol

Psychopharmacology

Volumn 114, Issue 2, 1994, Pages 288-296

  Cole, J C ^a   Rodgers, R J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anxiolytic; Behavioural suppression; Buspirone; Elevated plus maze; Ethological analysis; Haloperidol; Mice

Indexed keywords

BUSPIRONE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ETHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANXIETY; BEHAVIOR, ANIMAL; BUSPIRONE; COMPARATIVE STUDY; EXPLORATORY BEHAVIOR; HALOPERIDOL; MALE; MICE; MICE, INBRED DBA; POSTURE; RISK-TAKING; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0028332455     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244851     Document Type: Article

References (53)

1. Studies on the effects of 5-HT1A drugs in the pigeon
2. “Taming” of wild rats (Rattus rattus) by 5-HT1A agonists buspirone and gepirone
3. Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery
4. “Paradoxical” effects of morphine on antipredator defense reactions in wild and laboratory (R. norvegicus) rats
5. The characterization and modelling of antipredator defensive behavior
6. Effects of ethanol and diazepam on reactivity to predatory odors
7. Attenuation of antipredator defensive behaviour in rats following chronic treatment with imipramine
8. Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze
9. Actions of sulpiride and tiapride in a simple model of anxiety in mice
10. Effects in the X-maze model of agents acting at 5-HT1 and 5-HT2 receptors
11. An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice
12. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus-maze
13. Serotonergic mechanisms in the behavioral effects of buspirone
14. Resistance of baseline activity in the elevated plus-maze to exogenous influences
15. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal
16. Effects of subchronic treatment with chlordiazepoxide, busprione and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice
17. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
18. A comparison of the social postures of some common laboratory rodents
19. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties
20. Effects of buspirone in the Geller-Seifter conflict test with incremental shock
21. The 5-HT receptor family: ligands, distribution and receptor-effector coupling
22. Agonists and antagonists at 5-HT receptor subtypes
23. Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action
24. 5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety
25. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats
26. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone
27. Effects of buspirone in antinociceptive and behavioural responses to the elevated plus-maze
28. The use of a plus-maze to measure anxiety in the mouse
29. Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone
30. The relation between fear induced by novelty stimulation and exploratory behaviour
31. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone
32. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone
33. Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze
34. Dose-response analysis of the effects of buspirone on rearing in rats
35. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat
36. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
37. Selective agonists and antagonists for 5-Hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat
38. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine
39. A step in the right direction: comment on “5-HT and mechanisms of defence”
40. Anxiety enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors
41. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP
42. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone
43. Serotonergic anxiolytics: a review of their clinical efficacy
44. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test
45. Buspirone and related compounds as alternative anxiolytics
46. Pharmacological and clinical effects of buspirone
47. Inhibition of aggressive behavior in rhesus monkeys by buspirone
48. Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models
49. Effects of DN-2337, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze